Balloon shield may reduce radiation damage in prostate cancer treatment

NCT ID NCT06599476

Ongoing Disease control Sponsor: Advanced Radiation Centers of New York Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a biodegradable balloon, called a rectal spacer, placed between the prostate and rectum before radiation therapy for prostate cancer. The goal is to see if it safely reduces radiation exposure to the rectum, potentially lowering side effects. Up to 150 men with localized prostate cancer will be followed for two years after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BioProtect Balloon Implant System (a biodegradable balloon placed between the prostate and rectum)
What this could lead to: If it works, this could make radiation therapy for prostate cancer safer by reducing damage to the rectum, leading to fewer side effects.
What could go wrong: This is a single-group study without a comparison group, so it's unclear if the spacer is better than standard care. The balloon insertion also carries a small risk of infection or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Advanced Radiation Centers of New York

New Hyde Park, New York, 11042, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.